UBS AM’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.07M | Sell |
|
|||||
|
2025
Q2 | $9.63M | Sell |
|
|||||
|
2025
Q1 | $11.7M | Buy |
|
|||||
|
2024
Q4 | $16.6M | Buy |
|
|||||
|
2024
Q3 | $13.9M | Buy |
|
|||||
|
2024
Q2 | $11.7M | Buy |
|
|||||
|
2024
Q1 | $9.92M | Buy |
|
|||||
|
2023
Q4 | $2.25M | Buy |
|
|||||
|
2023
Q3 | $1.87M | Buy |
|
|||||
|
2023
Q2 | $221K | Hold |
|
|||||
|
2023
Q1 | $221K | Sell |
|
|||||
|
2022
Q4 | $477K | Hold |
|
|||||
|
2022
Q3 | $512K | Buy |
|
|||||
|
2022
Q2 | $256K | Sell |
|
|||||
|
2022
Q1 | $330K | Sell |
|
|||||
|
2021
Q4 | $653K | Buy |
|
|||||
|
2021
Q3 | $340K | Hold |
|
|||||
|
2021
Q2 | $304K | Buy |
|
|||||
|
2021
Q1 | $222K | Hold |
|
|||||
|
2020
Q4 | $205K | Buy |
|
|||||
|
2020
Q3 | $165K | Sell |
|
|||||
|
2020
Q2 | $583K | Buy |
|